Hua Medicine Revenue and Competitors
Estimated Revenue & Valuation
- Hua Medicine's estimated annual revenue is currently $1.9M per year.
- Hua Medicine's estimated revenue per employee is $71,400
Employee Data
- Hua Medicine has 27 Employees.
- Hua Medicine grew their employee count by 17% last year.
Hua Medicine's People
Name | Title | Email/Phone |
---|
Hua Medicine Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $34.9M | 548 | 18% | N/A | N/A |
#9 | $50.2M | 394 | -5% | N/A | N/A |
#10 | $13.6M | 243 | -10% | N/A | N/A |
What Is Hua Medicine?
åŽé¢†åŒ»è¯æŠ€æœ¯(上海)有é™å…¬å¸ is a research company based out of ä¸å›½(上海)自由贸易试验区爱迪生路275å·, 上海市, 上海市, China.
keywords:N/AN/A
Total Funding
27
Number of Employees
$1.9M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hua Medicine News
2022-04-20 - Study reviews COVID-related hospital visitation limits and ...
The study, published today in JAMA Internal Medicine, reports that nearly ... Timothy Amass, Lauren Jodi Van Scoy, May Hua, Melanie Ambler,...
2022-03-30 - Explainer | Traditional Chinese medicine (TCM) and Covid-19 ...
Traditional Chinese medicine (TCM) and Covid-19 what you need to know about its uses, including the one in Hong Kong's anti-pandemic kit. As...
2022-03-30 - Natural Remedies for Covid: China Tries to Promote ...
WATCH: Hong Kong and Shanghai have been distributing traditional Chinese medicine as the cities battle Covid-19. Source: Bloomberg. Active...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 27 | 23% | N/A |
#2 | $5.3M | 28 | -7% | N/A |
#3 | $3.5M | 30 | 15% | N/A |
#4 | $3.6M | 31 | 11% | N/A |
#5 | N/A | 31 | 7% | N/A |